Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mg
Clinical trial NCT00826358 · COMPLETED
Trial details
- NCT number
- NCT00826358
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2008-11-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.